PMID- 17584736 OWN - NLM STAT- MEDLINE DCOM- 20071019 LR - 20231213 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 282 IP - 33 DP - 2007 Aug 17 TI - Dissection of a signaling pathway by which pathogen-associated molecular patterns recruit the JNK and p38 MAPKs and trigger cytokine release. PG - 24246-54 AB - Pathogen-associated molecular patterns (PAMPs), molecular moieties produced by invading microbial pathogens, initiate innate immune responses by binding to pattern recognition receptors (PRRs). Engagement of PRRs elicits a wide variety of responses, including the production and release of cytokines and chemokines. These responses require the activation of several parallel signaling pathways, including NF-kappaB, the interferon regulatory factors, and the MAPKs. The JNK and p38 MAPK groups are major PRR effectors and are key to the PRR-dependent induction and release of proinflammatory cytokines such as tumor necrosis factor and interleukin-8. The mammalian Ste20 orthologue germinal center kinase (GCK) is required for the activation of JNK by a subset of PAMPs; however, the mechanisms by which GCK couples to downstream events remain unclear. Here we show that GCK is required for JNK and, unexpectedly, p38 activation by three bacterial PAMPs, lipopolysaccharide, peptidoglycan, and flagellin (FliC). We show that these same PAMPs, in a GCK-dependent manner, activate mixed lineage kinases-2 and -3, MAPK kinase kinases upstream of JNK, and p38. We also show that MLK2 and -3 are required for activation of JNK and p38 by ectopically expressed GCK. Finally, we show that MLK2 and -3 are required for lipopolysaccharide, peptidoglycan, and FliC recruitment of JNK and p38 as well as for PAMP recruitment of the transcription factor c-Jun, and for the induction of interleukin-8. Our results define a signaling pathway whereby PAMPs can trigger MAPK activation and gene expression. FAU - Zhong, Jian AU - Zhong J AD - Molecular Cardiology Research Institute, Department of Medicine, Tufts-New England Medical Center and the Boston, Massachusetts 02111, USA. FAU - Kyriakis, John M AU - Kyriakis JM LA - eng GR - R01-GM46577/GM/NIGMS NIH HHS/United States GR - T32-HL069770/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20070621 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Cytokines) RN - 0 (Germinal Center Kinases) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 8) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) RN - EC 2.7.11.25 (MAP Kinase Kinase Kinases) RN - EC 2.7.11.25 (MAP3K10 protein, human) SB - IM MH - Bacteria/*pathogenicity MH - Cytokines/metabolism MH - Germinal Center Kinases MH - Humans MH - Immunity, Innate MH - JNK Mitogen-Activated Protein Kinases/*metabolism MH - Jurkat Cells MH - MAP Kinase Kinase Kinases/physiology MH - MAP Kinase Signaling System MH - Mitogen-Activated Protein Kinase 8/*metabolism MH - Protein Serine-Threonine Kinases/metabolism/*physiology MH - Signal Transduction/*immunology MH - p38 Mitogen-Activated Protein Kinases/*metabolism MH - Mitogen-Activated Protein Kinase Kinase Kinase 11 EDAT- 2007/06/23 09:00 MHDA- 2007/10/20 09:00 CRDT- 2007/06/23 09:00 PHST- 2007/06/23 09:00 [pubmed] PHST- 2007/10/20 09:00 [medline] PHST- 2007/06/23 09:00 [entrez] AID - S0021-9258(20)54408-6 [pii] AID - 10.1074/jbc.M703422200 [doi] PST - ppublish SO - J Biol Chem. 2007 Aug 17;282(33):24246-54. doi: 10.1074/jbc.M703422200. Epub 2007 Jun 21.